Hepatobiliary Cancer
One Tumour, Four Experts – An Exploration of Decision-Making in Complex Liver Tumours

Hepatobiliary carcinoma is no longer a single-path disease.

As interventional oncology, hepatology and hepatobiliary surgery continue to advance, the treatment landscape is becoming more dynamic — and more complex. Patients today may have multiple therapeutic options available, from image-guided locoregional therapies to surgical resection and evolving multidisciplinary strategies.

But with more options comes a critical question: how do clinicians decide the best path forward for each patient?

In this case-based webinar, a panel of experts from across the hepatobiliary care spectrum will examine real clinical scenarios and debate the decisions that shape patient outcomes. Through multidisciplinary discussion, the session will explore how imaging, liver function, tumour biology, and patient context influence treatment strategy.

The panel features Professor Charles Sanyika, HoD of Interventional Radiology at Wits Donald Gordon Medical Center;  Professor Eduard Jonas, Professor of Surgery and Head of the Surgical Gastroenterology Unit at UCT and Groote Schuur Hospital; Dr Waldemar Szpak, Oncologist in private practice at Rainbow Oncology; Dr Bilal Bobat, Gastroenterologist, Hepatologist and Transplant Surgeon at Wits Donald Gordon Medical Center.

Together, they will unpack the evolving role of minimally invasive therapies, the continuing place of surgery, and how multidisciplinary decision-making is shaping the future of hepatobiliary cancer care.

Don’t miss this opportunity to explore how experts from across disciplines approach complex hepatobiliary cancer decisions in real-world clinical practice.